10x Genomics
NasdaqGS:TXG
$ 23,02
+ $1,20 (5,50%)
23,02 $
+$1,20 (5,50%)
End-of-day quote: 04/08/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,12
Earnings Per Share
$5,03
Revenue Per Share
69,05%
Gross Margin %
$2,79 B
Market Cap
$0,02 B
Long-Term Debt
Earnings Per Share
$0,12
Revenue Per Share
$5,03
Gross Margin %
69,05%
Market Cap
$2,79 B
Long-Term Debt
$0,02 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019
EPS Earnings Per Share $0,12 $-0,35 $-0,23 $-0,26 $-0,53 $-0,91 $-0,80
Earnings Earnings $15,33M $-42,81M $-27,41M $-29,99M $-59,81M $-98,96M $-77,24M
RPS Revenue Per Share $5,03 $4,99 $5,19 $4,48 $4,35 $2,75 $2,55
Revenue Revenue $642,82M $610,79M $618,73M $516,41M $490,49M $298,85M $245,89M
OCF Operating Cash Flow $150,00M $6,66M $-15,20M $-33,61M $-21,37M $-217,90M $34,63M
FCF Free Cash Flow $-59,00M $-5,73M $-63,80M $-165,27M $-122,65M $-254,56M $-8,12M
OM Operating Margin -17,25% -31,51% -32,28% -31,71% -10,79% -28,55% -11,82%
GM % Gross Margin % 69,05% 67,91% 66,15% 76,75% 84,89% 80,44% 75,18%
FCFS Free Cash Flow Per Share $0,00 $-0,06 $-0,55 $-1,45 $-1,11 $-2,53 $-0,21
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A $19,84M
Sha. Stocks 127,75M 122,3M 119,17M 115,36M 112,84M 108,75M 96,55M
×